Evaluating the Effectiveness of ChemoNurs: A Mobile Chemotherapy Drug Guide for Oncology Nurses - A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 59
- 试验地点
- 1
- 主要终点
- Change in Attitudes Toward Chemotherapy Practices
研究概览
简要总结
This study aimed to evaluate the effectiveness of a mobile chemotherapy drug guide application, ChemoNurs, developed for oncology nurses, in improving their knowledge and attitudes toward chemotherapy practices.
H1: The mobile chemotherapy drug guide developed for oncology nurses increases their knowledge related to chemotherapy.
H2: The mobile chemotherapy drug guide developed for oncology nurses promotes the development of positive attitudes toward chemotherapy.
H3: The mobile chemotherapy drug guide developed for oncology nurses increases their satisfaction.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Outcomes Assessor)
盲法说明
An independent statistician and a doctoral student working as a research assistant were responsible for the randomization and group assignment processes. Their involvement ensured the systematic conduct of the study and helped control selection bias through randomized allocation and allocation concealment. Due to the researcher's awareness of the intervention, blinding during the implementation phase was not feasible.
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Actively administering chemotherapy treatments
- •Having knowledge of how to use an Android or iOS smartphone
- •Possessing mobile literacy
- •Working in oncology clinics for a duration of 0-12 months
- •Volunteering to participate in the study
排除标准
- •Not having completed the orientation process in oncology clinics
- •Not having administered chemotherapy
- •Incomplete responses in the data collection forms
- •Willingness to withdraw at any stage of the study
- •Participation in the Oncology Nursing Certification Program
- •Prior attendance in courses or training sessions related to chemotherapy drugs
研究组 & 干预措施
Application Group
Participants in the experimental group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months.
干预措施: ChemoNurs Mobile Application Group (Other)
Application Group
Participants in the experimental group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months.
干预措施: Personal Smartphone (Device)
Standard Practice
Participants in the control group were oncology nurses working at Hacettepe University Oncology Hospital who continued with their routine clinical duties without access to the CHEMONURS mobile application or any additional educational intervention. After completing the baseline assessment using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, no further intervention was provided. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months, in parallel with the experimental group, to evaluate changes over time in the absence of the mobile application.
结局指标
主要结局
Change in Attitudes Toward Chemotherapy Practices
时间窗: Baseline (Month 0), Midpoint (Month 3), and Endpoint (Month 6)
This outcome measures changes in the attitudes of oncology nurses toward chemotherapy practices, using the Attitude Scale for Oncology Nurses Regarding Chemotherapy Practices. This scale was developed by Khan et al. (2012) to evaluate the attitudes of cancer nurses toward chemotherapy practices. It is a 4-point Likert-type scale with the following response options: 4 = Strongly Agree, 3 = Agree, 2 = Disagree, 1 = Strongly Disagree. The scale consists of two subdimensions: negative attitude (6 items) and positive attitude (4 items). The items under the negative attitude subdimension are reverse-scored when calculating the total score. The overall score ranges from a minimum of 10 to a maximum of 40, with higher scores indicating more positive attitudes toward chemotherapy practices.
Change in Chemotherapy Knowledge Score
时间窗: Baseline (Month 0), Midpoint (Month 3), and Endpoint (Month 6)
This outcome evaluates the improvement in oncology nurses' knowledge of chemotherapy administration, assessed through the Chemotherapy Practice Knowledge Scale for Oncology Nurses. The items are scored to assess nurses' knowledge related to chemotherapy practices using a 3-point Likert scale: "I have knowledge = 3," "I am unsure = 2," and "I have no knowledge = 1." The scale consists of 44 items and four subdimensions. The total score ranges from a minimum of 44 to a maximum of 132, with higher scores indicating greater knowledge regarding chemotherapy administration.
Change in Attitudes Toward Chemotherapy Practices
时间窗: Baseline (Month 0), Midpoint (Month 3), and Endpoint (Month 6)
This outcome measures changes in the attitudes of oncology nurses toward chemotherapy practices, using the Attitude Scale for Oncology Nurses Regarding Chemotherapy Practices. This scale was developed by Khan et al. (2012) to evaluate the attitudes of cancer nurses toward chemotherapy practices. It is a 4-point Likert-type scale with the following response options: 4 = Strongly Agree, 3 = Agree, 2 = Disagree, 1 = Strongly Disagree. The scale consists of two subdimensions: negative attitude (6 items) and positive attitude (4 items). The items under the negative attitude subdimension are reverse-scored when calculating the total score. The overall score ranges from a minimum of 10 to a maximum of 40, with higher scores indicating more positive attitudes toward chemotherapy practices.
Change in Chemotherapy Knowledge Score
时间窗: Baseline (Month 0), Midpoint (Month 3), and Endpoint (Month 6)
This outcome evaluates the improvement in oncology nurses' knowledge of chemotherapy administration, assessed through the Chemotherapy Practice Knowledge Scale for Oncology Nurses. The items are scored to assess nurses' knowledge related to chemotherapy practices using a 3-point Likert scale: "I have knowledge = 3," "I am unsure = 2," and "I have no knowledge = 1." The scale consists of 44 items and four subdimensions. The total score ranges from a minimum of 44 to a maximum of 132, with higher scores indicating greater knowledge regarding chemotherapy administration.
次要结局
- Mobile Application Usability(Month 3 and Month 6)
- Mobile Application Usability(Month 3 and Month 6)
- Nurses' Satisfaction with CHEMONURS Application(Month 6)
- Nurses' Satisfaction with CHEMONURS Application(Month 6)
研究者
Enes Simsek
Principal Investigator
Koç University